Search results
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 5 days agoThose who are more vulnerable to getting sick during a spring or summer surge may benefit from the...
Antibody-displaying extracellular vesicles for targeted cancer therapy - Nature Biomedical...
Nature· 7 days agoExtracellular vesicles decorated with an antibody-binding moiety specific for the fragment crystallizable domain can be used as a modular delivery system for targeted cancer therapy.
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions of Undisclosed Antibodies...
JD Supra· 5 days agoAmgen...
What Is the Rarest Blood Type?
Verywell Health via Yahoo News· 4 days agoHowever, there are several different subtypes of A, B, and Rh antigens. Sometimes, genetic testing can provide even more precise test results than...
Experimental HIV Vaccine Successfully Triggers Potent Antibodies in Humans
ScienceAlert via Yahoo News· 6 days agoThe phase I clinical trial, which began in 2019, enrolled 24 healthy participants, 4 of whom received a placebo. But the trial was halted after one person had a severe allergic ...
Could FLiRT Variants Cause Another Covid-19 Surge?
Forbes· 6 days agoA new Covid-19 variant known as KP.2, or FLiRT, began to emerge in the United States in early March of this year. This dramatic rise signals that KP.2...
Outbreak of Human Trichinellosis ...
Centers for Disease Control and Prevention· 4 days agoThe index patient’s diagnosis was confirmed by a positive Trichinella immunoglobulin (Ig) G antibody test result. Six days before symptom onset in the...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 2 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 5 days agoAnother, known as volrustomig, binds to PD-1 and a target called CTLA-4, essentially duplicating a...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoMultiple refractory PD1 failure patients experienced prolonged progression free survival (10 months ongoing); confirmed responses observed in patients receiving evalstotug High doses of evalstotug as either a monotherapy or in combination with